Sanofi - 16 Year Stock Price History | SNY

Historical daily share price chart and data for Sanofi since 2002 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Sanofi as of November 16, 2018 is 45.10.
Sanofi Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 40.9486 41.3523 45.5900 36.9039 45.1000 9.87%
2017 43.6100 37.8714 48.3111 36.4773 41.0468 9.94%
2016 36.5752 37.3699 39.3578 33.9783 37.3359 -1.15%
2015 42.8065 39.0394 48.6872 36.7589 37.7684 -3.45%
2014 43.6357 42.8417 49.1338 38.0789 39.1166 -11.90%
2013 41.8410 38.3253 45.8799 36.2299 44.3981 17.17%
2012 31.3107 28.4525 38.0933 26.7445 37.8934 35.70%
2011 26.9559 24.2429 30.8751 23.5412 27.9251 17.30%
2010 24.4689 29.0851 29.6052 20.8746 23.8071 -14.92%
2009 22.9683 22.0770 28.7716 16.8971 27.9807 28.83%
2008 23.4146 29.5219 31.5529 17.1403 21.7191 -26.25%
2007 28.0387 29.1219 31.2037 24.9681 29.4507 1.06%
2006 28.4203 28.2234 31.5582 25.9967 29.1408 7.32%
2005 25.6369 24.1861 27.9698 22.3387 27.1533 11.57%
2004 20.7903 22.3762 24.5811 17.2613 24.3380 9.66%
2003 17.4223 18.0223 22.1940 13.2380 22.1940 25.74%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $113.115B $39.599B
Sanofi-Aventis is a global pharmaceutical company that contributes to enhance life by providing medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States. The company is engaged in the research, development, manufacture and marketing of healthcare products. Its strategy is built around three priorities to reach its goals and ensure sustainable growth. The priorities are: increasing innovation in Research and Development, adapting Group structures to future challenges and seizing external growth opportunities. Sanofi-Aventis specializes in six therapeutic areas: thrombosis, cardiovascular, metabolic disorders, oncology, central nervous system (CNS) and internal medicine. The Company offers vaccines in five areas: pediatric combination vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines. Sanofi-Aventis is headquartered in Paris, France.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $391.677B 18.36
Pfizer (PFE) United States $259.009B 14.60
Merck (MRK) United States $205.072B 17.77
Novartis AG (NVS) Switzerland $203.357B 17.38
AbbVie (ABBV) United States $137.681B 12.22
Eli Lilly (LLY) United States $120.583B 21.20
Novo Nordisk (NVO) Denmark $107.931B 17.53
AstraZeneca (AZN) United Kingdom $103.013B 12.79
GlaxoSmithKline (GSK) United Kingdom $100.041B 13.45
Bristol-Myers Squibb (BMY) United States $88.253B 14.53